149 related articles for article (PubMed ID: 3686335)
1. Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique.
Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
Strahlenther Onkol; 1987 Nov; 163(11):723-8. PubMed ID: 3686335
[TBL] [Abstract][Full Text] [Related]
2. Cell loss from viable and necrotic tumour regions measured by 125I-UdR.
Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
Cell Tissue Kinet; 1983 Nov; 16(6):549-56. PubMed ID: 6627346
[TBL] [Abstract][Full Text] [Related]
3. Cell loss from viable and necrotic tumor regions after local gamma irradiation measured by 125I-UdR.
Bornschein R; Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
Strahlenther Onkol; 1987 Feb; 163(2):114-22. PubMed ID: 3563871
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of radio- and chemotoxic effects of 125I-UdR on tumour growth and host survival.
Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
Radiat Environ Biophys; 1985; 24(3):219-26. PubMed ID: 4034927
[TBL] [Abstract][Full Text] [Related]
5. Cell loss from three established lines of the C3H mouse mammary tumor: a comparison of the 125I-UdR and the 3H-TdR-autoradiographic methods.
Dethlefsen LA; Sorenson J; Snively J
Cell Tissue Kinet; 1977 Sep; 10(5):447-59. PubMed ID: 922798
[TBL] [Abstract][Full Text] [Related]
6. Cell population growth and cell loss in the MTG-B mouse mammary carcinoma.
Clifton KH; Yatvin MB
Cancer Res; 1970 Mar; 30(3):658-64. PubMed ID: 5425291
[No Abstract] [Full Text] [Related]
7. Non-specific esterase activity in reactive cells in injured nervous tissue labeled with 3H-thymidine or 125iododeoxyuridine injected before injury.
Schelper RL; Adrian EK
J Comp Neurol; 1980 Dec; 194(4):829-44. PubMed ID: 7204643
[TBL] [Abstract][Full Text] [Related]
8. [3H]thymidine labels less than half of the DNA-synthesizing cells in the mouse tumour, carcinoma NT.
Hamilton E; Dobbin J
Cell Tissue Kinet; 1982 Jul; 15(4):405-11. PubMed ID: 7105131
[TBL] [Abstract][Full Text] [Related]
9. The use of 5-(125I)iodo-2'-deoxyuridine for monitoring DNA synthesis in organ culture.
Riches AC; Gore D; Docherty J; Littlewood V
J Anat; 1976 Apr; 121(Pt 2):323-9. PubMed ID: 58855
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
Bloomer WD; Adelstein SJ
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic evidence for reutilization of DNA catabolites by granulocytopoiesis in the rat.
Gerecke D; Gross R
Scand J Haematol; 1976 Aug; 17(2):132-42. PubMed ID: 968445
[TBL] [Abstract][Full Text] [Related]
12. The differentiation of T lymphocytes. V. Evidence for intrathymic death of most thymocytes.
McPhee D; Pye J; Shortman K
Thymus; 1979 Nov; 1(3):151-62. PubMed ID: 317932
[TBL] [Abstract][Full Text] [Related]
13. The percentage labelled mitoses technique shows the mean cell cycle time to be half its true value in Carcinoma NT. II. [3H]deoxyuridine studies.
Hamilton E; Dobbin J
Cell Tissue Kinet; 1983 Sep; 16(5):483-92. PubMed ID: 6883432
[TBL] [Abstract][Full Text] [Related]
14. Fate of thymocytes: studies with 125I-iododeoxyuridine and 3H-thymidine in mice.
Joel DD; Chanana AD; Cottier H; Cronkite EP; Laissue JA
Cell Tissue Kinet; 1977 Jan; 10(1):57-69. PubMed ID: 300654
[TBL] [Abstract][Full Text] [Related]
15. Cell loss and influx of labeled host cells in three transplantable mouse tumors using [125I]UdR release.
Franko AJ; Kallman RF
Cell Tissue Kinet; 1980 Jul; 13(4):381-93. PubMed ID: 7428012
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tumor radioactivity after the administration of either 125I- or 3H-labeled 5-iodo-2'-deoxyuridine.
Dethlefsen LA
Cancer Res; 1969 Sep; 29(9):1717-20. PubMed ID: 5822480
[No Abstract] [Full Text] [Related]
17. [DNA Turnover in the Whole Body of Tumour Bearing Mice (author's transl)].
Kronenberger PH; Porschen W; Feinendegen LE
Beitr Pathol; 1976 Dec; 159(4):398-412. PubMed ID: 1022223
[TBL] [Abstract][Full Text] [Related]
18. Reutilization of 131I-5-iodo-2'-deoxyuridine as compared to 3H-thymidine in mouse duodenum and mammary tumor.
Dethlefsen LA
J Natl Cancer Inst; 1970 Apr; 44(4):827-40. PubMed ID: 11515050
[No Abstract] [Full Text] [Related]
19. The validity of the labelling index in tumour studies.
Hamilton E; Dobbin J
Br J Cancer; 1985 Jan; 51(1):15-21. PubMed ID: 3966970
[TBL] [Abstract][Full Text] [Related]
20. The percentage labelled mitoses technique shows the mean cell cycle time to be half its true value in Carcinoma NT. I. [3H]thymidine and vincristine studies.
Hamilton E; Dobbin J
Cell Tissue Kinet; 1983 Sep; 16(5):473-81. PubMed ID: 6883431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
